Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03663712
Title Talimogene Laherparepvec for the Treatment of Peritoneal Surface Malignancies (TEMPO)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dan Blazer III, M.D.

ovarian cancer

gastrointestinal system cancer


Talimogene laherparepvec

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.